These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25275487)

  • 1. Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's disease.
    Cheng S; LeBlanc KJ; Li L
    PLoS One; 2014; 9(9):e108845. PubMed ID: 25275487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
    Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD.
    Wang Q; Xiao B; Cui S; Song H; Qian Y; Dong L; An H; Cui Y; Zhang W; He Y; Zhang J; Yang J; Zhang F; Hu G; Gong X; Yan Z; Zheng Y; Wang X
    Dis Model Mech; 2014 Dec; 7(12):1385-95. PubMed ID: 25481013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
    Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
    Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
    Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
    CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.
    Xuan AG; Pan XB; Wei P; Ji WD; Zhang WJ; Liu JH; Hong LP; Chen WL; Long DH
    Mol Neurobiol; 2015 Feb; 51(1):300-12. PubMed ID: 24854198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice.
    Nunes AF; Amaral JD; Lo AC; Fonseca MB; Viana RJ; Callaerts-Vegh Z; D'Hooge R; Rodrigues CM
    Mol Neurobiol; 2012 Jun; 45(3):440-54. PubMed ID: 22438081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
    Trujillo-Estrada L; Jimenez S; De Castro V; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; Navarro V; Sanchez-Varo R; Sanchez-Mejias E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Acta Neuropathol Commun; 2013 Nov; 1():73. PubMed ID: 24252759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide attenuated injury via inhibiting oxidative stress in Amyloid-Beta25-35-treated differentiated PC12 cells.
    Xu P; Wang H; Li Z; Yang Z
    Life Sci; 2016 Jan; 145():19-26. PubMed ID: 26679104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.